Renal Cancer - Results from #2500

Black race may be associated with worse overall survival in renal cell carcinoma patients. September 23, 2020

Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma. September 23, 2020

Immune evasion in renal cell carcinoma: biology, clinical translation, future directions. September 22, 2020

Novel Therapeutic Approaches and the Evolution of Drug Development in Advanced Kidney Cancer. September 22, 2020

Androgen receptor modulates metastatic routes of VHL wild-type clear cell renal cell carcinoma in an oxygen-dependent manner. September 22, 2020

The Role of Targeted Therapy in the Management of High-Risk Resected Kidney Cancer: What Have We Learned and How Will It Inform Future Adjuvant Trials. September 21, 2020

Immune Related Adverse Events: Classification and Management Approaches in Advanced Kidney Cancer. September 21, 2020

Biopsy Cell Cycle Proliferation Score Predicts Adverse Surgical Pathology in Localized Renal Cell Carcinoma. September 21, 2020

A Phase I, Open-label, Dose-escalation, and Cohort Expansion Study to Evaluate the Safety and Immune Response to Autologous Dendritic Cells Transduced With AdGMCA9 (DC-AdGMCAIX) in Patients With Metastatic Renal Cell Carcinoma. September 18, 2020

Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors. September 18, 2020

The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes. September 18, 2020

Contemporary trends in percutaneous renal mass biopsy utilization in the United States. September 17, 2020

Preoperative nomogram predicting 12-year probability of metastatic renal cancer - evaluation in a contemporary cohort. September 17, 2020

Mass Spectrometry Imaging Differentiates Chromophobe Renal Cell Carcinoma and Renal Oncocytoma with High Accuracy. September 17, 2020

Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK-228) in advanced solid tumours, with an expansion phase in renal, endometrial or bladder cancer. September 16, 2020

Proliferative potential and response to nivolumab in clear cell renal cell carcinoma patients. September 16, 2020

Patient factors predict complications after partial nephrectomy: Validation and calibration of the PREP (Preoperative Risk Evaluation for Partial Nephrectomy) score. September 16, 2020

Clear cell renal cell carcinoma with osseous metaplasia: Two extremely rare cases and review of the literature. September 15, 2020

Pathological features and outcomes of incidental renal cell carcinoma in candidate solid organ donors. September 15, 2020

Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review. September 15, 2020

Page 126 of 456